Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeres Power Regulatory News (CWR)

Share Price Information for Ceres Power (CWR)

Share Price is delayed by 15 minutes
Get Live Data
609.50    -40.50 (-6.23%)
Bid:
606.50
Ask:
614.50
Spread: 8.00 (1.319%)
Market Cap: £1.19b
CWR Live PriceLast checked at - London Stock Exchange

Intraday Ceres Power Share Chart

Directorate Change

30 Oct 2014 15:24

RNS Number : 7549V
Ceres Power Holdings plc
30 October 2014
 



30 October 2014

Ceres Power Holdings Plc

("Ceres Power" or the "Company")

Directorate Change

Ceres Power Holdings plc, a world leading developer of low cost, next generation fuel cell technology, is pleased to announce the appointment of Dr Mark Selby to the Board of the Company as Chief Technology Officer with immediate effect.

Dr Selby joined Ceres Power in 2006 and was appointed as Director of Technology in 2013. He is responsible for leading all aspects of the development and delivery of the Steel Cell technology. Prior to joining Ceres Power, he held several senior roles at Ricardo UK Limited. Dr Selby has degrees in Electronics, Dynamics and Control Systems awarded by the University of Leeds.

Phil Caldwell, Chief Executive of Ceres Power, said:

"I am delighted that Mark is joining the Board, this is a reflection of his significant contribution to the excellent technical and commercial progress which the Company has made in the last year."

Further information:

In accordance with Schedule Two (g) and Rule 17 of the AIM Rules for Companies, the following information in relation to the appointment of Dr Selby is disclosed:

Mark Albert Selby, aged 37, is or has been a director of the following companies during the previous five years:

Current:

Ceres Power Limited

Ceres Intellectual Property Company Limited

 

Past five years:

Nil

Dr Selby is interested in 25,325 ordinary shares of the Company representing approximately 0.003% of the Company's issued share capital. In addition, Dr Selby holds a total of 3,603,312 shares under option as follows:

Shares under option

Exercise price

1,600,000

1p

360,000

8.54p

1,500,000

8.5p

143,312 (Sharesave options)

6.28p

Other than the information provided above, there is no further information to be disclosed under Schedule Two (g) and Rule 17 of the AIM Rules for Companies.

Enquiries:

Ceres Power Holdings plc

Phil Caldwell, CEO

Richard Preston, CFO

Tel. +44 (0)1403 273 463

N+1 Singer (Nominated Adviser and Broker)

Andrew Craig / Ben Wright / Alex Wright

Tel: +44 (0) 20 7496 3000

Tavistock Communications

Mike Bartlett/James Collins

Tel: +44 (0) 20 7920 3150

Notes to editors:

About Ceres Power

 

Ceres Power (http://www.cerespower.com/) is a world leading developer of low cost, next generation fuel cell technology for use in decentralised energy products that reduce operating costs, lower CO2 emissions, increase efficiency and improve energy security. The Ceres unique patented Steel Cell technology operates on mains natural gas and is manufactured using standard manufacturing processes and conventional materials such as steel, meaning that it can be mass produced at an affordable price for domestic and business use.

 

www.cerespower.com 

 

 

Ends

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWGGUPUUPCGAU
Date   Source Headline
6th Oct 20257:00 amRNSHolding(s) in Company
3rd Oct 202511:30 amRNSHolding(s) in Company
2nd Oct 20257:01 amRNSHolding(s) in Company
2nd Oct 20257:00 amRNSHolding(s) in Company
30th Sep 202510:00 amRNSTotal Voting Rights
26th Sep 20257:00 amRNSInterim Results
2nd Sep 20257:00 amRNSNotice of Interim Results
29th Aug 202510:00 amRNSTotal Voting Rights
31st Jul 202510:00 amRNSTotal Voting Rights
28th Jul 20257:00 amRNS-RDoosan Fuel Cell and Ceres joint announcement
10th Jul 20254:05 pmRNSHolding(s) in Company
9th Jul 20255:25 pmRNSHolding(s) in Company
7th Jul 20254:46 pmRNSSALE OF ORDINARY SHARES IN CERES POWER
7th Jul 202510:00 amRNSBlock listing Interim Review
30th Jun 202510:00 amRNSTotal Voting Rights
27th Jun 202511:00 amRNSGrant of Long Term Incentive Plan (“LTIP”) Awards
16th Jun 20252:00 pmRNSGrant of Share Options under the Sharesave Scheme
30th May 202510:00 amRNSTotal Voting Rights
20th May 20257:00 amRNS-RFirst hydrogen production at MW-scale demonstrator
15th May 20253:15 pmRNSResult of AGM
30th Apr 20257:00 amRNSTotal Voting Rights
28th Apr 202511:30 amRNSDirector/PDMR Shareholding
11th Apr 202510:00 amRNSNotice of AGM & Publication of Annual Report
31st Mar 20257:00 amRNSTotal Voting Rights
21st Mar 20257:00 amRNSFinal results for the year ended 31 December 2024
11th Mar 20257:28 amRNSNotice of results and revised trading update
28th Feb 20257:00 amRNSTotal Voting Rights
20th Feb 202511:45 amRNSDirectorate Change
20th Feb 20257:00 amRNSStatement regarding Robert Bosch GmbH
31st Jan 20257:00 amRNSTotal Voting Rights
30th Jan 202510:30 amRNSDirector/PDMR Shareholding
29th Jan 20257:00 amRNSTrading update for the year ended 31 December 2024
28th Jan 20254:55 pmRNSHolding(s) in Company
14th Jan 202510:00 amRNSBlock Listing Application
7th Jan 20257:00 amRNSBlock listing Interim Review
31st Dec 20247:00 amRNSTotal Voting Rights
29th Nov 20247:00 amRNSTotal Voting Rights
28th Nov 20243:30 pmRNSNotifications of transactions by PDMRs
31st Oct 20247:00 amRNSTotal Voting Rights
9th Oct 20246:00 pmRNSWitan Investment Trust
7th Oct 20242:12 pmRNSGrant of Long Term Incentive Plan Awards
3rd Oct 20243:36 pmRNSNotifications of transactions by PDMRs
30th Sep 20247:00 amRNSTotal Voting Rights
27th Sep 20247:00 amRNSInterim results for the six months ended 30 June
12th Sep 20249:58 amRNSCeres signs Thermax as SOEC system partner
6th Sep 20247:00 amRNSBoard change: Appointment of Stuart Paynter as CFO
4th Sep 20247:00 amRNSNotice of Results
30th Aug 20247:00 amRNSTotal Voting Rights
6th Aug 20247:05 amRNSCeres and Denso partnership investor meeting today
6th Aug 20247:00 amRNSCeres confirms Denso as the latest licence partner

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.